© 2018 RSM US LLP. All rights reserved.
Life Sciences Case Studies
RSM provides a variety of tax, accounting and consulting services to innovative life sciences organizations throughout the country, including pharmaceuticals, biopharmaceuticals, biotechnology, clinical research, and medical device manufacturers and suppliers. In the case studies below, learn how our clients have benefitted from working with RSM.
RSM’s industry and technical knowledge provided Egalet with a managed IT strategy to align organizational goals with technology solutions.
Royalty review discovers omitted products, unallowable deductions, unreported sales and nearly $4.5 million in underpaid royalties.
RSM built a finance and accounting outsourcing solution to help a growing company enhance performance, reduce costs and optimize operations.
RSM worked with InteguRX to develop a comprehensive FAO solution for more financial visibility and consistency that will scale with growth.
RSM’s integrated delivery platform gave Amring Pharmaceuticals increased visibility into business processes, efficiency and independence.
Covance, a life sciences company, wanted to improve its approach to managing global reporting and compliance requirements.
This case study focuses on the importance of a deep understanding in life sciences company valuations. Learn more.
RSM helped Moderna implement a NetSuite purchasing and payment solution with increased process automation, efficiency and accountability.
Learn how RSM helped a pharmaceutical company realize better, timelier service through a tax outsourcing arrangement.
With IPO on the line, RSM delivers valuation client needs to finance the future.
Life Sciences Insights
Contact Our Team
EVENTS / WEBCASTS
Healthcare-focused private equity, lending and finance conference will explore ways to successfully close transactions and achieve growth.
This recorded webcast provides an overview of the key provisions of the new tax bill and how they affect life sciences companies.
ON DEMAND WEBCAST
View this webcast to learn how the new revenue recognition standard (ASC 606) affects the life sciences industry (CPE eligible).